IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Founders Fund VII Management, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 2 holdings | $24.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abcellera Biologics Inc(ABCL)COM00288U106$21.5M3,773,53089.8%
Compass Pathways PLC(CMPS)SPONSORED ADS20451W101$2.4M278,88010.2%